In view of these results, we analyzed EPC populations in RA patients according to IFNα levels and disease duration, using as controls healthy donors (HC) and patients with SLE, a disease presenting altered levels of IFNα and EPCs [24]. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.